These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9226874)

  • 1. Correlation of Pseudomonas aeruginosa virulence factors from clinical and environmental isolates with pathogenicity in the neutropenic mouse.
    Woods DE; Lam JS; Paranchych W; Speert DP; Campbell M; Godfrey AJ
    Can J Microbiol; 1997 Jun; 43(6):541-51. PubMed ID: 9226874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract, and wound infections.
    Hamood AN; Griswold JA; Duhan CM
    J Surg Res; 1996 Mar; 61(2):425-32. PubMed ID: 8656619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of exoproducts to virulence of Pseudomonas aeruginosa.
    Nicas TI; Iglewski BH
    Can J Microbiol; 1985 Apr; 31(4):387-92. PubMed ID: 2988728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of elastase and other exoproducts by environmental isolates of Pseudomonas aeruginosa.
    Nicas TI; Iglewski BH
    J Clin Microbiol; 1986 May; 23(5):967-9. PubMed ID: 3086372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extracellular enzymes of Pseudomonas aeruginosa as virulence factors].
    Jaeger KE
    Immun Infekt; 1994 Oct; 22(5):177-80. PubMed ID: 7982713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites.
    Woods DE; Schaffer MS; Rabin HR; Campbell GD; Sokol PA
    J Clin Microbiol; 1986 Aug; 24(2):260-4. PubMed ID: 3018037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and characterization of chromosomal insertional mutations of the Pseudomonas aeruginosa exoenzyme S trans-regulatory locus.
    Frank DW; Nair G; Schweizer HP
    Infect Immun; 1994 Feb; 62(2):554-63. PubMed ID: 8300213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of exoenzyme S to the virulence of Pseudomonas aeruginosa.
    Nicas TI; Iglewski BH
    Antibiot Chemother (1971); 1985; 36():40-8. PubMed ID: 2988426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and genetic aspects of Pseudomonas aeruginosa virulence.
    Lory S; Tai PC
    Curr Top Microbiol Immunol; 1985; 118():53-69. PubMed ID: 2414071
    [No Abstract]   [Full Text] [Related]  

  • 10. Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosa.
    Sokol PA; Iglewski BH; Hager TA; Sadoff JC; Cross AS; McManus A; Farber BF; Iglewski WJ
    Infect Immun; 1981 Oct; 34(1):147-53. PubMed ID: 6271678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of infections owing to Pseudomonas aeruginosa using the burned mouse model: experimental studies from the Shriners Burns Institute, Cincinnati.
    Holder IA
    Can J Microbiol; 1985 Apr; 31(4):393-402. PubMed ID: 3924388
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations.
    Grimwood K; To M; Rabin HR; Woods DE
    Antimicrob Agents Chemother; 1989 Jan; 33(1):41-7. PubMed ID: 2496657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of exotoxin A in inducing severe Pseudomonas aeruginosa infections in mice.
    Miyazaki S; Matsumoto T; Tateda K; Ohno A; Yamaguchi K
    J Med Microbiol; 1995 Sep; 43(3):169-75. PubMed ID: 7650723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal studies of virulence factors of Pseudomonas aeruginosa in cystic fibrosis.
    Burke V; Robinson JO; Richardson CJ; Bundell CS
    Pathology; 1991 Apr; 23(2):145-8. PubMed ID: 1745565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis.
    Grimwood K; Semple RA; Rabin HR; Sokol PA; Woods DE
    Pediatr Pulmonol; 1993 Mar; 15(3):135-9. PubMed ID: 8327274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of toxin A excretion-deficient mutants of Pseudomonas aeruginosa PAO1.
    Hamood AN; Ohman DE; West SE; Iglewski BH
    Infect Immun; 1992 Feb; 60(2):510-7. PubMed ID: 1730483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S.
    Nicas TI; Iglewski BH
    Infect Immun; 1984 Aug; 45(2):470-4. PubMed ID: 6086529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa.
    Mizukane R; Hirakata Y; Kaku M; Ishii Y; Furuya N; Ishida K; Koga H; Kohno S; Yamaguchi K
    Antimicrob Agents Chemother; 1994 Mar; 38(3):528-33. PubMed ID: 8203850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Significance of Pseudomonas aeruginosa virulence factors for acute and chronic Pseudomonas aeruginosa infections].
    Döring G
    Infection; 1987; 15 Suppl 2():S38-41. PubMed ID: 3112018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and genetic studies of iron-regulated (exotoxin A) and phosphate-regulated (hemolysin phospholipase C) virulence factors of Pseudomonas aeruginosa.
    Vasil ML; Berka RM; Gray GL; Pavlovskis OR
    Antibiot Chemother (1971); 1985; 36():23-39. PubMed ID: 2988425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.